デフォルト表紙
市場調査レポート
商品コード
1594558

肥満症手術機器市場:タイプ別、手技別-2025-2030年の世界予測

Obesity Surgery Devices Market by Type (Minimally Invasive Surgical Devices, Non-Invasive Surgical Devices), Procedure (Adjustable Gastric Banding, Biliopancreatic Diversion with Duodenal Switch, Gastric Bypass) - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 181 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
肥満症手術機器市場:タイプ別、手技別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

肥満症手術機器市場は、2023年に40億7,000万米ドルと評価され、2024年には43億9,000万米ドルに達すると予測され、CAGR 7.91%で成長し、2030年には69億4,000万米ドルに達すると予測されています。

肥満症手術機器市場の範囲には、胃バンド、胃バルーン、その他の肥満手術器具など、肥満に悩む人々の減量を支援するために設計された医療器具の範囲が含まれます。これらの器具は主に肥満手術に使用され、糖尿病、高血圧、心疾患などの肥満関連合併症の有病率の上昇により、ますます不可欠となっています。主なエンドユーザーは、病院、外来手術センター、専門クリニックなどです。外科的介入に対する意識の高まりと保険適用の改善が市場を牽引しています。主な成長要因としては、侵襲性の低い手技の技術的進歩、世界の肥満率の増加、健康とウェルネスを推進する政府の支持的イニシアティブなどが挙げられます。一方、最新のビジネスチャンスは、低侵襲手術装置の開発と、ヘルスケアインフラの改善による新興国市場の拡大にあります。

主な市場の統計
基準年[2023] 40億7,000万米ドル
予測年[2024] 43億9,000万米ドル
予測年[2030] 69億4,000万米ドル
CAGR(%) 7.91%

しかし、高い手術費用、潜在的な術後合併症、非外科的脂肪減少ソリューションの人気の高まりなどが大きな課題となっており、市場の成長は制限されています。さらに、厳しい規制状況や、これらの手術を実施するための熟練した専門家の要件が障壁として作用する可能性があります。逆に、技術革新の展望は、手術手技の強化、より効果的で患者に優しい機器の開発、手術結果の改善と術後ケアの管理のためのAIの統合にあります。医療機器メーカーとヘルスケアプロバイダーが協力して研究や文化的受容を促進することで、市場拡大の道が開けるかもしれないです。肥満症手術機器市場は、ウェアラブル技術、リアルタイムモニタリング、個別化医療アプローチにおけるイノベーションから大きな影響を受ける可能性があります。全体として、市場は競争的かつダイナミックであり、持続可能な成長を確保し、増加する肥満の世界的負担に対処するために、継続的な調査とヘルスケア動向や規制基準への適応が求められます。

市場力学:急速に進化する肥満症手術機器市場の主要市場インサイトを公開

肥満症手術機器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 世界の肥満人口の増加
    • 体重管理とフィットネスに関する意識の高まり
    • 肥満手術と低侵襲手術の増加
  • 市場抑制要因
    • 製品リコールと先進手術器具の高コスト
  • 市場機会
    • 肥満症手術機器における技術の進歩
    • 世界の医療ツーリズムの台頭
  • 市場の課題
    • 手術に伴うリスク、合併症、副作用

ポーターの5つの力:肥満症手術機器市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:肥満症手術機器市場における外部からの影響の把握

外部マクロ環境要因は、肥満症手術機器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析肥満症手術機器市場における競合情勢の把握

肥満症手術機器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス肥満症手術機器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、肥満症手術機器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨肥満症手術機器市場における成功への道筋を描く

肥満症手術機器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界の肥満人口の蔓延率
      • 体重管理とフィットネスに関する意識の高まり
      • 肥満手術と低侵襲手術の増加
    • 抑制要因
      • 高度な手術機器の製品リコールと高コスト
    • 機会
      • 肥満症手術機器における技術的進歩
      • 世界中で医療ツーリズムが増加
    • 課題
      • 手術に伴うリスク、合併症、副作用
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 肥満症手術機器市場:タイプ別

  • 低侵襲手術機器
    • アクセサリー
    • ステープルデバイス
    • 縫合器具
  • 非侵襲性外科用機器

第7章 肥満症手術機器市場手順別

  • 調節性胃バンディング
  • 十二指腸スイッチによる胆膵バイパス術
  • 胃バイパス
  • ミニ胃バイパス
  • 非侵襲性肥満手術
  • 肥満手術の再手術
  • スリーブ状胃切除術

第8章 南北アメリカの肥満症手術機器市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の肥満症手術機器市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの肥満症手術機器市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Agency for Medical Innovation
  • Allergan Inc. by AbbVie Inc.
  • Apollo Endosurgery, Inc.
  • B. Braun Melsungen AG
  • Bariatec Corporation
  • Cousin Biotech
  • Intuitive Surgical Inc.
  • Johnson & Johnson Services Inc.
  • Medtronic PLC
  • Olympus Corporation
  • ReShape Lifesciences, Inc.
  • Spatz FGIA, Inc.
  • Standard Bariatrics, Inc.
  • Stryker Corporation
  • TransEnterix Surgical, Inc.
図表

LIST OF FIGURES

  • FIGURE 1. OBESITY SURGERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. OBESITY SURGERY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES OBESITY SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES OBESITY SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. OBESITY SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. OBESITY SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OBESITY SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OBESITY SURGERY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY STAPLING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SUTURING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY NON-INVASIVE SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MINI-GASTRIC BYPASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY NON-INVASIVE BARIATRIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY REVISION BARIATRIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES OBESITY SURGERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM OBESITY SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM OBESITY SURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 149. OBESITY SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. OBESITY SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-036C5CF3A89F

The Obesity Surgery Devices Market was valued at USD 4.07 billion in 2023, expected to reach USD 4.39 billion in 2024, and is projected to grow at a CAGR of 7.91%, to USD 6.94 billion by 2030.

The scope of the obesity surgery devices market encompasses a range of medical devices designed to aid in weight loss for individuals suffering from obesity, including gastric bands, gastric balloons, and other bariatric surgical tools. These devices are primarily used in bariatric surgeries, which are increasingly essential due to the rising prevalence of obesity-related complications like diabetes, hypertension, and cardiac problems. The key end-users include hospitals, ambulatory surgical centers, and specialty clinics. Increasing awareness about surgical interventions and improved insurance coverage are driving the market. Key growth factors include technological advancements in less invasive procedures, growing rates of obesity globally, and supportive government initiatives promoting health and wellness. Meanwhile, the latest opportunities lie in the development of minimally invasive surgical devices and expanding markets in developing regions due to improving healthcare infrastructure.

KEY MARKET STATISTICS
Base Year [2023] USD 4.07 billion
Estimated Year [2024] USD 4.39 billion
Forecast Year [2030] USD 6.94 billion
CAGR (%) 7.91%

However, market growth is limited by high surgical costs, potential post-surgical complications, and the growing popularity of non-surgical fat loss solutions, which pose a significant challenge. Additionally, the stringent regulatory landscape and the requirement for skilled professionals to conduct these surgeries can act as barriers. Conversely, innovation prospects lie in the enhancement of surgical techniques, development of more effective and patient-friendly devices, and integration of AI for improved surgical outcomes and management of post-operative care. Collaborations between medical device companies and healthcare providers to foster research and cultural acceptance may pave the way for market expansion. The obesity surgery devices market could see a profound impact from innovations in wearable technology, real-time monitoring, and personalized medicine approaches. Overall, the market is competitive and dynamic, demanding continuous research and adaptation to healthcare trends and regulatory standards to ensure sustainable growth and address the increasing global burden of obesity.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Obesity Surgery Devices Market

The Obesity Surgery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of obese population worldwide
    • Growing awareness regarding weight management and fitness
    • Growing number of bariatric surgeries and minimally invasive procedures
  • Market Restraints
    • Product recall and high cost of advanced surgery devices
  • Market Opportunities
    • Technological advancements in obesity surgery devices
    • Rise of medical tourism worldwide
  • Market Challenges
    • Associated risks, complications and side effects of surgery

Porter's Five Forces: A Strategic Tool for Navigating the Obesity Surgery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Obesity Surgery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Obesity Surgery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Obesity Surgery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Obesity Surgery Devices Market

A detailed market share analysis in the Obesity Surgery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Obesity Surgery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Obesity Surgery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Obesity Surgery Devices Market

A strategic analysis of the Obesity Surgery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Obesity Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include Agency for Medical Innovation, Allergan Inc. by AbbVie Inc., Apollo Endosurgery, Inc., B. Braun Melsungen AG, Bariatec Corporation, Cousin Biotech, Intuitive Surgical Inc., Johnson & Johnson Services Inc., Medtronic PLC, Olympus Corporation, ReShape Lifesciences, Inc., Spatz FGIA, Inc., Standard Bariatrics, Inc., Stryker Corporation, and TransEnterix Surgical, Inc..

Market Segmentation & Coverage

This research report categorizes the Obesity Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Minimally Invasive Surgical Devices and Non-Invasive Surgical Devices. The Minimally Invasive Surgical Devices is further studied across Accessories, Stapling Devices, and Suturing Devices.
  • Based on Procedure, market is studied across Adjustable Gastric Banding, Biliopancreatic Diversion with Duodenal Switch, Gastric Bypass, Mini-Gastric Bypass, Non-Invasive Bariatric Surgery, Revision Bariatric Surgery, and Sleeve Gastrectomy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of obese population worldwide
      • 5.1.1.2. Growing awareness regarding weight management and fitness
      • 5.1.1.3. Growing number of bariatric surgeries and minimally invasive procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall and high cost of advanced surgery devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in obesity surgery devices
      • 5.1.3.2. Rise of medical tourism worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Associated risks, complications and side effects of surgery
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Obesity Surgery Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Minimally Invasive Surgical Devices
    • 6.2.1. Accessories
    • 6.2.2. Stapling Devices
    • 6.2.3. Suturing Devices
  • 6.3. Non-Invasive Surgical Devices

7. Obesity Surgery Devices Market, by Procedure

  • 7.1. Introduction
  • 7.2. Adjustable Gastric Banding
  • 7.3. Biliopancreatic Diversion with Duodenal Switch
  • 7.4. Gastric Bypass
  • 7.5. Mini-Gastric Bypass
  • 7.6. Non-Invasive Bariatric Surgery
  • 7.7. Revision Bariatric Surgery
  • 7.8. Sleeve Gastrectomy

8. Americas Obesity Surgery Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Obesity Surgery Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Obesity Surgery Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agency for Medical Innovation
  • 2. Allergan Inc. by AbbVie Inc.
  • 3. Apollo Endosurgery, Inc.
  • 4. B. Braun Melsungen AG
  • 5. Bariatec Corporation
  • 6. Cousin Biotech
  • 7. Intuitive Surgical Inc.
  • 8. Johnson & Johnson Services Inc.
  • 9. Medtronic PLC
  • 10. Olympus Corporation
  • 11. ReShape Lifesciences, Inc.
  • 12. Spatz FGIA, Inc.
  • 13. Standard Bariatrics, Inc.
  • 14. Stryker Corporation
  • 15. TransEnterix Surgical, Inc.